Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DYNPORT VACCINE COMPANY LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2017-03-22 to 2022-07-31
Current total value of award: $24654605.59
Description: THIS AWARD PROVIDES FOR CLINICAL TRIALS THAT WILL ASSESS THE LONG TERM OPHTHALMIC SAFETY OF TAFENOQUINE (TQ) AFTER 12 MONTHS OF EXPOSURE.